Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 4046-4054

  Gopinathan, Unni ^a,b   Øvstebø, Reidun ^a   Olstad, Ole Kristoffer ^a   Brusletto, Berit ^a   Aass, Hans Christian Dalsbotten ^a   Kierulf, Peter ^a,b   Brandtzaeg, Petter ^a,b   Berga, Jens Petter ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ARTICLE; CELL DEATH; CELL MOTILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MENINGOCOCCEMIA; MONOCYTE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; MENINGOCOCCAL INFECTIONS; MONOCYTES; NEISSERIA MENINGITIDIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; SHOCK, SEPTIC;

EID: 84867605405     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00386-12     Document Type: Article

References (54)

1. Antoniv TT, Park-Min K-H, Ivashkiv LB. 2005. Kinetics of IL-10-induced gene expression in human macrophages. Immunobiology 210: 87-95.
2. Asadullah K, Sterry W, Volk HD. 2003. Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55:241-269.
3. Ayala JM, et al. 1994. IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J. Immunol. 153:2592-2599.
4. Bjerre A, Brusletto B, øvstebø R, Joø GB, Kierulf P, Brandtzaeg P. 2003. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex. J. Endotoxin Res. 9:155-163.
5. Brandtzaeg P, Bjerre A, øvstebø R, Brusletto B, Joø GB, Kierulf P. 2001. Neisseria meningitidis lipopolysaccharides in human pathology. J. Endotoxin Res. 7:401-420.
6. Brandtzaeg P, et al. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159:195-204.
7. Brandtzaeg P, et al. 1996. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J. Exp. Med. 184:51-60.
8. Brandtzaeg P, Ovstebø R, Kierulf P. 1992. Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J. Infect. Dis. 166:650-652.
9. Brown D, Trowsdale J, Allen R. 2004. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64:215-225.
10. Brown DP, et al. 2009. The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection. BMC Immunol. 10:56.
11. Chin AI, et al. 2002. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416:190-194.
12. Couper KN, Blount DG, Riley EM. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180:5771-5777.
13. Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S. 1995. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J. Infect. Dis. 171:229-232.
14. Farina C, Theil D, Semlinger B, Hohlfeld R, Meinl E. 2004. Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int. Immunol. 16:799-809.
15. Gross O, Thomas CJ, Guarda G, Tschopp J. 2011. The inflammasome: an integrated view. Immunol. Rev. 243:136-151.
16. He C-X, Prevot N, Boitard C, Avner P, Rogner UC. 2010. Inhibition of type 1 diabetes by upregulation of the circadian rhythm-related aryl hydrocarbon receptor nuclear translocator-like 2. Immunogenetics 62:585-592.
17. Hochart H, et al. 2008. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood. Thromb. Haemost. 99:570-575.
18. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644-658.
19. Høgåsen AK, Abrahamsen TG. 1995. Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production. Thromb. Res. 80:179-184.
20. Janský L, Reymanová P, Kopecký J. 2003. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol. Res. 52:593-598.
21. Katzav S. 2009. Vav1: a hematopoietic signal transduction molecule involved in human malignancies. Int. J. Biochem. Cell Biol. 41:1245-1248.
22. Kuwata H, et al. 2003. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102:4123-4129.
23. Landrette SF, et al. 2005. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood 105:2900-2907.
24. Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. 2002. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169:2253-2263.
25. Lee DJ, et al. 2007. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J. Immunol. 179:8128-8136.
26. Leemans JC, Cassel SL, Sutterwala FS. 2011. Sensing damage by the NLRP3 inflammasome. Immunol. Rev. 243:152-162.
27. Lehmann AK, Halstensen A, Sørnes S, Røkke O, Waage A. 1995. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect. Immun. 63:2109-2112.
28. -ΔΔCT method. Methods 25: 402-408.
29. Lu C, et al. 2005. Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity. J. Biol. Chem. 280:16278-16283.
30. Lu HK, et al. 2012. LILRA2 selectively modulates LPS-mediated cytokine production and inhibits phagocytosis by monocytes. PLoS One 7:e33478. doi:10.1371/journal.pone.0033478.
31. Lund PK, Joø GB, Westvik AB, Ovstebø R, Kierulf P. 2000. Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand. J. Clin. Lab. Invest. 60:357-365.
32. Mariathasan S, et al. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213-218.
33. Martinon F, Burns K, Tschopp J. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10:417-426.
34. Mazzoccoli G, et al. 2012. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J. Cancer Res. Clin. Oncol. 138:501-511.
35. Meyaard L. 2008. The inhibitory collagen receptor LAIR-1 (CD305). J. Leukoc. Biol. 83:799-803.
36. Mitchell A, et al. 2008. LILRA5 is expressed by synovial tissue macrophages in rheumatoid arthritis, selectively induces pro-inflammatory cytokines and IL-10 and is regulated by TNF-alpha, IL-10 and IFN-gamma. Eur. J. Immunol. 38:3459-3473.
37. Murray PJ. 2005. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. U. S. A. 102:8686-8691.
38. Murray PJ. 2006. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 6:379-386.
39. Nembrini C, et al. 2009. The kinase activity of Rip2 determines its stability and consequently Nod1-and Nod2-mediated immune responses. J. Biol. Chem. 284:19183-19188.
40. Netea MG, et al. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113:2324-2335.
41. O'Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C. 2008. Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 223:114-131.
42. Ovstebø R, et al. 2004. Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J. Clin. Microbiol. 42:2980-2987.
43. Ovstebø R, et al. 2008. Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains. Infect. Immun. 76:2685-2695.
44. Park J-H, et al. 2007. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178:2380-2386.
45. Piehler AP, Grimholt RM, Ovstebø R, Berg JP. 2010. Gene expression results in lipopolysaccharide-stimulated monocytes depend significantly on the choice of reference genes. BMC Immunol. 11:21.
46. Rietschel ET, et al. 1996. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216:39-81.
47. Rojahn A, Brusletto B, øvstebø R, Haug KBF, Kierulf P, Brandtzaeg P. 2008. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock? Crit. Care Med. 36:2583-2589.
48. Sabat R, et al. 2010. Biology of interleukin-10. Cytokine Growth Factor Rev. 21:331-344.
49. Stephens DS, Greenwood B, Brandtzaeg P. 2007. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369:2196-2210.
50. Strowig T, Henao-Mejia J, Elinav E, Flavell R. 2012. Inflammasomes in health and disease. Nature 481:278-286.
51. Takaoka A, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249.
52. van Deuren M, Brandtzaeg P, van der Meer JW. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13:144-166.
53. Wessells J, et al. 2004. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J. Biol. Chem. 279:49995-50003.
54. Williams L, Jarai G, Smith A, Finan P. 2002. IL-10 expression profiling in human monocytes. J. Leukoc. Biol. 72:800-809.